London close: Second wind lifts Footsie higher
20th Sep 2010 16:40
A strong start on Wall Street ensured Footsie finished with good gains having started the day on a strong footing. US shares moved ahead including housebuilder and economic bellwether Lennar, which beat profit forecasts. Part-nationalised banking giant Lloyds Banking held up well after it was ann
Read moreLondon afternoon: Lloyds up as Daniels names exit date
20th Sep 2010 14:29
Stocks gave up a proportion of their gains over the lunch time session despite expectations of a firm start on Wall Street. Part-nationalised banking giant Lloyds Banking is holding up well after it was announced that chief executive Eric Daniels is to retire in a year's time. The move was not unex
Read moreLondon midday: US coast guard verdicts lifts BP
20th Sep 2010 12:09
Investors are in an optimistic frame of mind ahead of the Federal Reserve's Federal Open Market Committee (FOMC) meeting tomorrow. The 'glass half full' crowd are expecting the FOMC to announce further measures to revitalise the global economy. Barely a dozen Footsie constituents are in the red, an
Read moreInterdigm integration lifts losses at Silence
20th Sep 2010 07:22
Bid target Silence Therapeutics said 2010 has been a pivotal year with the company making advances in the three areas it sees as the most important in the coming years: partnerships, intellectual property and clinical progress. Looking at the numbers, the company, which specialises in pharmaceutica
Read moreSilence Therapeutics rockets on bid approach
6th Sep 2010 17:43
Silence Therapeutics gained more than three quarters of its value Monday on news of a bid approach. The AIM-listed firm, involved in developing RNA interference (RNAi) therapeutics to treat serious diseases, was trading at just 5p three weeks ago. It had risen to 7.24p on Friday and then to 12.75p
Read moreUK SMALLCAP ROUNDUP:Dividend Chance For International Greetings
14th Jul 2010 16:00
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps INTERNATIONAL GREETINGS PLC (IGR.LN) Wednesday said it isn't ruling out introducing its first dividend payment at the end of the current fiscal year.
Read moreSmall caps: Silence Therapeutics, Eros, Interquest,...
14th Jul 2010 14:01
Silence Therapeutics has agreed a one-year extension of its ongoing research and development collaboration with AstraZeneca. The pair are working on five therapeutic molecules addressing respiratory and oncology indications. Film distributor Eros traded well in the second half of the financial year
Read moreUK SMALLCAP ROUNDUP: NXT's Cash Flow Pressured By Sales Fall
14th Jul 2010 12:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps NXT PLC (NXT.LN), U.K. technology and licensing company, Wednesday said fiscal 2010 revenue is "significantly down" on last year, in spite of an improvem
Read moreUK SMALLCAP ROUNDUP: ASOS Revenue Boosted By Overseas Sales
14th Jul 2010 09:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps ASOS PLC (ASC.LN), an online fashion retailer, Wednesday posted a 48% jump in first-quarter group revenue, helped by a more than doubling of overseas sal
Read moreSilence Therapeutics, AstraZeneca Extend Research Deal
14th Jul 2010 07:32
LONDON (Dow Jones)--Biotechnology company Silence Therapeutics PLC (SLN.LN) said Wednesday it extended a research deal with AstraZeneca PLC (AZN.LN) by another year. Silence specializes in RNA interference, an experimental branch of drug research which involves shutting off or silencing genes in
Read moreArk Therapeutics In Talks With Possible Buyers For Unit
13th Jul 2010 07:49
LONDON (Dow Jones)--Biotechnology company Ark Therapeutics Group PLC (AKT.LN) Tuesday said it is in talks with potential buyers of its wound care business. The company, which launched a strategic review after its experimental brain cancer medicine Cerepro was rejected by European drug regulators
Read moreThursday tips round-up: GKN, Drax, Xchanging
17th Dec 2009 06:10
GKN yesterday delivered its first upgrade to profit forecasts this year ? but you might not guess it from the shares in the aerospace and automotive engineer, which actually fell on the day. At 113½p, or eight times the best guess of 2011 earnings, the shares trade at a steep discount to US peers. B
Read more